Corrigendum to “The electronic medication complete communication (EMC2) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication safety in ambulatory care” [Contemp. Clin. Trials (Contemporary Clinical Trials (2016) (72–77) (S1551714416302452) (10.1016/j.cct.2016.10.005))

Stacy Cooper Bailey*, Michael K. Paasche-Orlow, William G. Adams, Samantha A. Brokenshire, Laura A. Hedlund, Ryan P. Hickson, Christine U. Oramasionwu, Amy L. Moore, Danielle M. McCarthy, Laura M. Curtis, Mary J. Kwasny, Michael S. Wolf

*Corresponding author for this work

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

The authors regret that there was an error in the list of authors in the original article. The list of authors and their affiliations have been updated correctly as above in this corrigendum.

Original languageEnglish (US)
Number of pages1
JournalContemporary Clinical Trials
Volume57
DOIs
StatePublished - Jun 1 2017

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Corrigendum to “The electronic medication complete communication (EMC2) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication safety in ambulatory care” [Contemp. Clin. Trials (Contemporary Clinical Trials (2016) (72–77) (S1551714416302452) (10.1016/j.cct.2016.10.005))'. Together they form a unique fingerprint.

  • Cite this